Stephen Mack

Stephen Mack is a Senior Research Scientist at Selcia since 2018, bringing extensive experience in medicinal chemistry and organic chemistry. Prior positions include Medicinal Chemist at Convergence Pharmaceuticals Ltd. for a brief tenure in 2017, and a substantive role as Medicinal Chemist at Takeda Cambridge from 2008 to 2016. Stephen began their career as a Synthetic Chemist at Aventis from 1997 to 2000 and held multiple medicinal chemistry roles at UCB/Celltech from 2000 to 2008. Academically, Stephen holds a PhD in Organic Chemistry and a degree in Natural Sciences, primarily focused on chemistry, both from the University of Cambridge.